isocoumarins has been researched along with Carcinoma, Lewis Lung in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Armstrong, ME; Bucala, R; Conroy, H; Cooke, G; Donnelly, SC; Fayne, D; Fingerle-Rowson, G; Keane, MP; Leng, L; Lloyd, D; Maher, L; Mawhinney, L; O' Reilly, C; Tynan, A | 1 |
| Beckett, MA; Gupta, VK; Hari, DM; Hellman, S; Jaskowiak, NT; Kalluri, R; Koons, AM; Kufe, DW; Mauceri, HJ; Posner, MC; Reimer, C; Salloum, RM; Seetharam, S; Weichselbaum, RR | 1 |
2 other study(ies) available for isocoumarins and Carcinoma, Lewis Lung
| Article | Year |
|---|---|
Macrophage migration inhibitory factor (MIF) enzymatic activity and lung cancer.
Topics: Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Cell Line; Dinoprostone; Female; Intramolecular Oxidoreductases; Isocoumarins; Lipopolysaccharides; Lung; Lung Neoplasms; Macrophage Migration-Inhibitory Factors; Mice, Inbred C57BL; Mice, Knockout; Tumor Burden; Tumor Necrosis Factor-alpha | 2015 |
NM-3, an isocoumarin, increases the antitumor effects of radiotherapy without toxicity.
Topics: Adenocarcinoma; Animals; Carcinoma, Lewis Lung; Cell Movement; Cells, Cultured; Collagen; Coumarins; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Combinations; Endothelium, Vascular; Esophageal Neoplasms; Female; Humans; Isocoumarins; Laminin; Mice; Mice, Inbred C57BL; Mice, Nude; Neoplasm Transplantation; Neoplasms; Proteoglycans; Radiation, Ionizing; Time Factors; Tumor Cells, Cultured; Umbilical Veins | 2000 |